Search Results - "Chopra, Vijay Kumar"

Cost-Consequence Analysis of Sacubitril/Valsartan versus Enalapril in Chronic Heart Failure Patients with Reduced Ejection Fraction by Gokhale, Sameer Bhaskar, Ray, Saumitra, Chopra, Vijay Kumar, Jadhav, Uday, Billa, Gauri

“…Purpose: The rising prevalence of heart failure (HF) in midlife years in Indians is posing an economic challenge. Sacubitril/valsartan demonstrated a…”
Get full text

ESC 2016 Heart Failure Guidelines: A Consensus Document from Indian Experts for Adaptation in India by Chopra, Vijay Kumar, Kumar, Soumitra, Dasbiswas, Arup, Desai, Devang, Ghoshroy, Debanu, Mohan, Jagdish Chander, Maddury, Srinivasa Rao

“…Heart Failure (HF) in chronic setting is an important cardiac cause of morbidity and mortality. HF burden in India is expected to increase because of…”
Get full text

Vascular Disease in Young Indians (20-40 years): Role of Ischemic Heart Disease by Dalal, Jamshed, Hiremath, Murugesh Shantaveeraya, Das, Mrinal Kanti, Desai, Devangkumar M, Chopra, Vijay Kumar, Biswas, Arup Das

“…Coronary Artery Disease (CAD) occurs at a younger age in Indians with over 50% of Cardiovascular Disease (CVD) mortality occurring in individuals aged less…”
Get full text

Why so Much Error in Analysts' Earnings Forecasts? by Chopra, Vijay Kumar

“…Wall Street analysts tend to be too optimistic about the earnings prospects of companies they follow. The average consensus 12-month EPS growth forecast is…”
Get full text

GENDER-BASED DIFFERENCES IN THE PRESENTATION AND OUTCOMES OF ACUTE DECOMPENSATED HEART FAILURE PATIENTS IN DEVELOPING COUNTRIES by Balagopalan, Jayagopal Pathiyil, Abdullakutty, Jabir, sastry, Sridhar Lakshmana, Nanjappa, Veena, Vaidyanathan, Peruvamba Raman, Chopra, Vijay Kumar, Sengupta, Shantanu, Arimpur, Geevar Z., Routray, Satyanarayan, Ravindranath, K.S., Srinivas, B.C., Manjunath, C. Nanjappa

Get full text

ODYSSEY EAST: Alirocumab efficacy and safety vs ezetimibe in high cardiovascular risk patients with hypercholesterolemia and on maximally tolerated statin in China, India, and Thailand by Han, Yaling, Chen, Jiyan, Chopra, Vijay Kumar, Zhang, Shuyang, Su, Guohai, Ma, Changsheng, Huang, Zhouqing, Ma, Yingyan, Yao, Zhuhua, Yuan, Zuyi, Zhao, Qiang, Kuanprasert, Srun, Baccara-Dinet, Marie T., Manvelian, Garen, Li, Jianyong, Chen, Rui

“…The proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab significantly reduces low-density lipoprotein cholesterol (LDL-C). This study (ODYSSEY…”
Get full text

Charting a roadmap for heart failure research in India: Insights from a qualitative survey by Harikrishnan, Sivadasanpillai, Koshy, Linda, Ganapathi, Sanjay, Jeemon, Panniyammakal, Kumar, Raman, Roy, Adrija, Reethu, S, Ramachandran, Surya, Lakshmikanth, L, Sharma, Meenakshi, Chopra, Vijay, Prabhakaran, Dorairaj, Kartha, C

“…Background & objectives: Heart failure (HF) is emerging as a major health problem in India. The profile of HF in India is divergent from elsewhere in the…”
Get full text

Suspecting and diagnosing transthyretin amyloid cardiomyopathy (ATTR-CM) in India: An Indian expert consensus by Chander Mohan, Jagdish, Dalal, Jamshed, Chopra, Vijay Kumar, Narasimhan, Calambur, Kerkar, Prafulla, Oomman, Abraham, Ray Fcsi, Saumitra, Sharma, Anshu Rajnish, Dougall, Pankaj, Simon, Shelley, Verma Drm, Atul, Radhakrishnan, Vivek

“…Transthyretin cardiac amyloidosis (ATTR-CM) is a rare and under-recognized disorder characterized by the aggregation of transthyretin-derived insoluble amyloid…”
Get full text

EFFICACY AND SAFETY OF LONG-TERM EVOLOCUMAB USE IN ASIAN VERSUS OTHER SUBJECTS: THE FOURIER TRIAL by Keech, Anthony C., Sever, Peter, Jiang, Lixin, Hirayama, Atsushi, Lu, Chen, Tay, Leslie, Deedwania, Prakash, Siu, Chung-Wah, Pineda, Armando Lira, Choi, Donghoon, Charng, Min-Ji, Amerena, John, Ahmad, Wan Azman Wan, Chopra, Vijay Kumar, Pedersen, Terje, Giugliano, Robert, Sabatine, Marc

Get full text

Suspecting and diagnosing transthyretin amyloid cardiomyopathy (ATTR-CM) in India: An Indian expert consensusKey recommendations by panel on patient journey and red flagsKey recommendations by the panel on tools for diagnosisKey recommendations by the panel on comparison of global ATTR-CM guidelines by Jagdish Chander Mohan, Jamshed Dalal, Vijay Kumar Chopra, Calambur Narasimhan, Prafulla Kerkar, Abraham Oomman, Saumitra Ray Fcsi, Anshu Rajnish Sharma, Pankaj Dougall, Shelley Simon, Atul Verma Drm, Vivek Radhakrishnan

“…Transthyretin cardiac amyloidosis (ATTR-CM) is a rare and under-recognized disorder characterized by the aggregation of transthyretin-derived insoluble amyloid…”
Get full text

Information asymmetry, price changes, trading volume and bid-ask spreads: Two essays by Chopra, Vijay Kumar

“…This dissertation examines the impact of information asymmetry on the behavior of prices and trading volume. The patterns in prices and trading volume arising…”
Get full text